tetano
Editor, Senior Moderator
PLoS One. 2018 Aug 8;13(8):e0200934. doi: 10.1371/journal.pone.0200934. eCollection 2018.
[h=1]Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.[/h] Mazagatos C[SUP]1,[/SUP][SUP]2[/SUP], Delgado-Sanz C[SUP]1,[/SUP][SUP]2[/SUP], Oliva J[SUP]1,[/SUP][SUP]2[/SUP], Gherasim A[SUP]1,[/SUP][SUP]2[/SUP], Larrauri A[SUP]1,[/SUP][SUP]2[/SUP]; Spanish Influenza Surveillance System.
[h=3]Author information[/h]
[h=3]Abstract[/h] Based on previous observations during pandemics and seasonal epidemics, pregnant women are considered at risk of developing severe influenza outcomes after influenza infection. With the aim of preventing severe influenza illness, the World Health Organization (WHO) includes pregnant women as a target group for seasonal influenza vaccination. However, influenza vaccine uptake during pregnancy remains low in many countries, including Spain. The objectives of this study were to increase the evidence of pregnancy as a risk factor for severe influenza illness and to study the potential role of seasonal influenza vaccination in the prevention of severe outcomes in infected pregnant women. Using information from the surveillance of Severe Hospitalized Confirmed Influenza Cases (SHCIC) in Spain, from seasons 2010/11 to 2015/16, we estimated that pregnant women in our study had a relative risk of hospitalization with severe influenza nearly 7.8 times higher than non-pregnant women of reproductive age. Only 5 out of 167 pregnant women with known vaccination status in our study had been vaccinated (3.6%). Such extremely low vaccination coverage only allowed obtaining crude estimates suggesting a protective effect of the vaccine against influenza complications (ICU admission or death). Our overall results support that pregnant women could benefit from seasonal influenza vaccination, in line with national and international recommendations.
PMID: 30089148 DOI: 10.1371/journal.pone.0200934
Free full text
[h=1]Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.[/h] Mazagatos C[SUP]1,[/SUP][SUP]2[/SUP], Delgado-Sanz C[SUP]1,[/SUP][SUP]2[/SUP], Oliva J[SUP]1,[/SUP][SUP]2[/SUP], Gherasim A[SUP]1,[/SUP][SUP]2[/SUP], Larrauri A[SUP]1,[/SUP][SUP]2[/SUP]; Spanish Influenza Surveillance System.
[h=3]Author information[/h]
[h=3]Abstract[/h] Based on previous observations during pandemics and seasonal epidemics, pregnant women are considered at risk of developing severe influenza outcomes after influenza infection. With the aim of preventing severe influenza illness, the World Health Organization (WHO) includes pregnant women as a target group for seasonal influenza vaccination. However, influenza vaccine uptake during pregnancy remains low in many countries, including Spain. The objectives of this study were to increase the evidence of pregnancy as a risk factor for severe influenza illness and to study the potential role of seasonal influenza vaccination in the prevention of severe outcomes in infected pregnant women. Using information from the surveillance of Severe Hospitalized Confirmed Influenza Cases (SHCIC) in Spain, from seasons 2010/11 to 2015/16, we estimated that pregnant women in our study had a relative risk of hospitalization with severe influenza nearly 7.8 times higher than non-pregnant women of reproductive age. Only 5 out of 167 pregnant women with known vaccination status in our study had been vaccinated (3.6%). Such extremely low vaccination coverage only allowed obtaining crude estimates suggesting a protective effect of the vaccine against influenza complications (ICU admission or death). Our overall results support that pregnant women could benefit from seasonal influenza vaccination, in line with national and international recommendations.
PMID: 30089148 DOI: 10.1371/journal.pone.0200934
Free full text